A Study of LY2216684 in Healthy Females

NCT01373931 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: LY2216684
DRUG: Ortho Cyclen
DRUG: Placebo

Sponsor

Eli Lilly and Company